Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 1
2007 2
2008 5
2012 1
2013 2
2014 4
2015 10
2016 14
2017 22
2018 14
2019 10
2020 18
2021 18
2022 10
2023 18
2024 17
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Guardiola J, Jahnsen J, Lees C, Louis E, Lukáš M, Reinisch W, Roblin X, Jang M, Byun HG, Kim DH, Lee SJ, Atreya R. Peyrin-Biroulet L, et al. Among authors: kim dh. BMC Gastroenterol. 2022 Jun 8;22(1):291. doi: 10.1186/s12876-022-02347-1. BMC Gastroenterol. 2022. PMID: 35676620 Free PMC article.
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials.
Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola, Jahnsen J, Louis E, Lukáš M, Reinisch W, Roblin X, Smith PJ, Kwon T, Kim J, Yoon S, Kim DH, Atreya R. Peyrin-Biroulet L, et al. Among authors: kim dh. BMC Gastroenterol. 2024 Mar 27;24(1):121. doi: 10.1186/s12876-024-03163-5. BMC Gastroenterol. 2024. PMID: 38539103 Free PMC article.
Combined Double-Pulley Remplissage and Bankart Repair.
Kim DH, Kim JY, Park J, Talwar M, Jenkins S, Gardner B, McGahan P, Chen JL. Kim DH, et al. Arthrosc Tech. 2022 Feb 18;11(3):e419-e425. doi: 10.1016/j.eats.2021.11.011. eCollection 2022 Mar. Arthrosc Tech. 2022. PMID: 35256986 Free PMC article.
Mycobacterium Tuberculosis in Spinal Tuberculosis.
Moon MS, Kim SS, Moon HL, Kim DH. Moon MS, et al. Among authors: kim dh. Asian Spine J. 2017 Feb;11(1):138-149. doi: 10.4184/asj.2017.11.1.138. Epub 2017 Feb 17. Asian Spine J. 2017. PMID: 28243382 Free PMC article. Review.
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial.
D'Haens G, Reinisch W, Schreiber S, Cummings F, Irving PM, Ye BD, Kim DH, Yoon S, Ben-Horin S. D'Haens G, et al. Among authors: kim dh. Clin Drug Investig. 2023 Apr;43(4):277-288. doi: 10.1007/s40261-023-01252-z. Epub 2023 Apr 1. Clin Drug Investig. 2023. PMID: 37004656 Free PMC article. Clinical Trial.
Noncanonical role of Golgi-associated macrophage TAZ in chronic inflammation and tumorigenesis.
Park SY, Ju S, Lee J, Kim HR, Sub Y, Park DJ, Park S, Kwon D, Kang HG, Shin JE, Kim DH, Paik JE, Cho SC, Shim H, Kim YJ, Guan KL, Chun KH, Choi J, Ha SJ, Gee HY, Roe JS, Lee HW, Park SY, Park HW. Park SY, et al. Among authors: kim dh. Sci Adv. 2025 Jan 24;11(4):eadq2395. doi: 10.1126/sciadv.adq2395. Epub 2025 Jan 22. Sci Adv. 2025. PMID: 39841821 Free PMC article.
157 results